Immune-Onc Therapeutics, Inc.
A Growth Lead, Partnerships & Community at MoldCo is responsible for managing partnership operations, affiliate programs, community engagement, podcast & media outreach, quality control, and ensuring compliance. This role involves building trust within patient communities, fostering relationships with partners, and supporting the company's growth initiatives in the healthcare space.
Headquarters
Palo Alto, California, United States
Company Size
11-50 employees
Founded
2016
Immune-Onc Therapeutics is a biotechnology company focused on developing next-generation immunotherapies that harness and reshape the immune system to treat cancer. The company advances a pipeline of novel biologics, cell- and antibody-based approaches targeting tumor-specific antigens and the tumor microenvironment, pursuing both monotherapies and rational combinations. Immune-Onc emphasizes translational research and strategic partnerships with academic and industry collaborators to accelerate clinical development and bring safer, more effective treatments to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Immune-Onc Therapeutics, Inc..
Immune-Onc Therapeutics, Inc. didn’t post a salary, so this is our estimate from similar listings.